Ruben J. de Boer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruben J. de Boer has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jarom Heijmans
Affiliations Amsterdam UMC, University of Amsterdam, department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands, Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands, Amsterdam Gastroenterology Endocrinology and Metabolism institute, Amsterdam, The Netherlands
2 shared publications Claudia N Spaan
Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC
1 shared publicationGijs R van Den Brink
Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC
1 shared publicationJacqueline Lm Vermeulen
Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC
1 shared publicationJoana Silva
Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands
1 shared publicationJonathan Hm van der Meer
Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC
1 shared publication
Latest Publications
- 14 February 2024
- Published by Elsevier in Cancer Letters
- Vol. 587, 216678
ER stress and the unfolded protein response in gastrointestinal stem cells and carcinogenesis
- 14 February 2024
- Published by Elsevier in Cancer Letters
- Vol. 587, 216678
ER stress and the unfolded protein response in gastrointestinal stem cells and carcinogenesis
- Open Access
- 29 August 2023
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (11) , e202301912
Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis
In development of colorectal cancer, mutations inAPCare often followed by mutations in oncogeneKRAS. The latter changes cellular metabolism and is associated with the Warburg phenomenon. Glucose-regulated protein 78 (Grp78) is an important regulator of the protein-folding machinery, involved in processing and localization of transmembrane proteins. We hypothesize that targetingGrp78inApcandKras(AK)-mutant intestines interferes with the metabolic phenotype imposed byKrasmutations. In mice with intestinal epithelial mutations inApc,KrasG12Dand heterozygosity forGrp78(AK-Grp78HET) adenoma number and size is decreased compared withAK-Grp78WTmice. Organoids fromAK-Grp78WTmice exhibited a glycolysis metabolism which was completely rescued byGrp78heterozygosity. Expression and correct localization of glucose transporter GLUT1 was diminished inAK-Grp78HETcells. GLUT1 inhibition restrained the increased growth observed inAK-mutant organoids, whereasAK-Grp78HETorganoids were unaffected. We identifyGrp78as a critical factor inKras-mutated adenomagenesis. This can be attributed to a critical role forGrp78in GLUT1 expression and localization, targeting glycolysis and the Warburg effect.
- 29 August 2023
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 6 (11) , e202301912
Open AccessGrp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis
In development of colorectal cancer, mutations inAPCare often followed by mutations in oncogeneKRAS. The latter changes cellular metabolism and is associated with the Warburg phenomenon. Glucose-regulated protein 78 (Grp78) is an important regulator of the protein-folding machinery, involved in processing and localization of transmembrane proteins. We hypothesize that targetingGrp78inApcandKras(AK)-mutant intestines interferes with the metabolic phenotype imposed byKrasmutations. In mice with intestinal epithelial mutations inApc,KrasG12Dand heterozygosity forGrp78(AK-Grp78HET) adenoma number and size is decreased compared withAK-Grp78WTmice. Organoids fromAK-Grp78WTmice exhibited a glycolysis metabolism which was completely rescued byGrp78heterozygosity. Expression and correct localization of glucose transporter GLUT1 was diminished inAK-Grp78HETcells. GLUT1 inhibition restrained the increased growth observed inAK-mutant organoids, whereasAK-Grp78HETorganoids were unaffected. We identifyGrp78as a critical factor inKras-mutated adenomagenesis. This can be attributed to a critical role forGrp78in GLUT1 expression and localization, targeting glycolysis and the Warburg effect.